FDA Inspection 897084 — Octapharma Plasma Inc

Octapharma Plasma Inc — FEI 2077837

The FDA completed an inspection of Octapharma Plasma Inc on September 17, 2014 in San Diego, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 17, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
San Diego, CA (United States)

Citations

IDCFRDescription
16121 CFR 606.160(a)(2)Determination of lot numbers and supplies